166 related articles for article (PubMed ID: 8451041)
1. Phase II study of high-dose ifosfamide as a single agent and in combination with cisplatin in the treatment of advanced and/or recurrent squamous cell carcinoma of head and neck.
Pai VR; Parikh DM; Mazumdar AT; Rao RS
Oncology; 1993; 50(2):86-91. PubMed ID: 8451041
[TBL] [Abstract][Full Text] [Related]
2. Phase II trial of paclitaxel, ifosfamide, and cisplatin in patients with recurrent head and neck squamous cell carcinoma.
Shin DM; Glisson BS; Khuri FR; Ginsberg L; Papadimitrakopoulou V; Lee JJ; Lawhorn K; Gillenwater AM; Ang KK; Clayman GL; Callender DL; Hong WK; Lippman SM
J Clin Oncol; 1998 Apr; 16(4):1325-30. PubMed ID: 9552033
[TBL] [Abstract][Full Text] [Related]
3. Recent advances in paclitaxel-containing chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck.
Shin DM; Glisson BS; Khuri FR; Ginsberg L; Lawhorn K; Hong WK; Lippman SM
Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-33-S19-37. PubMed ID: 9427263
[TBL] [Abstract][Full Text] [Related]
4. Clinical evaluation of two dosages and schedules of ifosfamide in combination with cisplatin in neo-adjuvant chemotherapy of patients with advanced (stage III-IV) head and neck squamous cell carcinoma: a phase II randomized study.
Mantovani G; Ghiani M; Lai P; Maccio A; Dessi D; Succu G; Massa D; Curreli L; Mulas C; Esu S; Proto E; Cadeddu G; Tore G
Oncol Rep; 1998; 5(6):1499-505. PubMed ID: 9769395
[TBL] [Abstract][Full Text] [Related]
5. A phase II study of ifosfamide in recurrent squamous cell carcinoma of the head and neck.
Huber MH; Lippman SM; Benner SE; Shirinian M; Dimery IW; Dunnington JS; Hong WK
Am J Clin Oncol; 1996 Aug; 19(4):379-82. PubMed ID: 8677909
[TBL] [Abstract][Full Text] [Related]
6. Role of paclitaxel, ifosfamide, and cisplatin in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.
Shin DM; Glisson BS; Khuri FR; Hong WK; Lippman SM
Semin Oncol; 1998 Apr; 25(2 Suppl 4):40-4; discussion 45-8. PubMed ID: 9578061
[TBL] [Abstract][Full Text] [Related]
7. Ifosfamide and mitoxantrone in the treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck.
Thurnher D; Kornfehl J; Burian M; Gedlicka C; Selzer E; Quint C; Neuchrist C; Kornek GV
Anticancer Drugs; 2001 Mar; 12(3):205-8. PubMed ID: 11290867
[TBL] [Abstract][Full Text] [Related]
8. Ifosfamide and mesna for the treatment of advanced squamous cell head and neck cancer. A GETLAC study.
Cervellino JC; Araujo CE; Pirisi C; Francia A; Cerruti R
Oncology; 1991; 48(2):89-92. PubMed ID: 1900124
[TBL] [Abstract][Full Text] [Related]
9. Dose-finding study of docetaxel added to ifosfamide and cisplatin followed by concomitant capecitabine and radiotherapy in the treatment of locally advanced squamous cell carcinoma of the head and neck.
Recchia F; Saggio G; Cesta A; Amiconi G; di Blasio A; Candeloro G; Valeriani M; Tombolini V; Rea S
Anticancer Res; 2006; 26(3B):2317-24. PubMed ID: 16821609
[TBL] [Abstract][Full Text] [Related]
10. Phase II study of induction chemotherapy with paclitaxel, ifosfamide, and carboplatin (TIC) for patients with locally advanced squamous cell carcinoma of the head and neck.
Shin DM; Glisson BS; Khuri FR; Lippman SM; Ginsberg L; Diaz E; Papadimitrakopoulou V; Feng L; Francisco M; Garden A; Kies MS; Myers J; Clayman G; Hong WK
Cancer; 2002 Jul; 95(2):322-30. PubMed ID: 12124833
[TBL] [Abstract][Full Text] [Related]
11. Ifosfamide, cisplatin, and 13-Cis retinoic acid for patients with advanced or recurrent squamous cell carcinoma of the head and neck: a phase I-II study.
Recchia F; Lalli A; Lombardo M; De Filippis S; Saggio G; Fabbri F; Rosselli M; Capomolla E; Rea S
Cancer; 2001 Aug; 92(4):814-21. PubMed ID: 11550152
[TBL] [Abstract][Full Text] [Related]
12. Clinical phase I study of paclitaxel followed by cisplatin in advanced head and neck squamous cell carcinoma.
Hanauske AR; Schilling T; Heinrich B; Kau R; Herzog M; Quasthoff S; Bochtler H; Diergarten K; Rastetter J
Semin Oncol; 1995 Dec; 22(6 Suppl 14):35-9. PubMed ID: 8553082
[TBL] [Abstract][Full Text] [Related]
13. Single-agent paclitaxel and paclitaxel plus ifosfamide in the treatment of head and neck cancer.
Forastiere AA; Urba SG
Semin Oncol; 1995 Jun; 22(3 Suppl 6):24-7. PubMed ID: 7597431
[TBL] [Abstract][Full Text] [Related]
14. Ifosfamide in the treatment of advanced or recurrent squamous cell carcinoma of the head and neck: a phase II Hoosier Oncology Group trial.
Sandler A; Saxman S; Bandealy M; Heilman D; Monaco F; McClean J; Arquette M
Am J Clin Oncol; 1998 Apr; 21(2):195-7. PubMed ID: 9537211
[TBL] [Abstract][Full Text] [Related]
15. Chemotherapy with paclitaxel, ifosfamide, and cisplatin for the treatment of squamous cell cervical cancer: the experience of Monza.
Zanetta G; Fei F; Mangioni C
Semin Oncol; 2000 Feb; 27(1 Suppl 1):23-7. PubMed ID: 10697040
[TBL] [Abstract][Full Text] [Related]
16. A phase II evaluation of a 3-hour infusion of paclitaxel, cisplatin, and 5-fluorouracil in patients with advanced or recurrent squamous cell carcinoma of the head and neck: Southwest Oncology Group study 0007.
Worden FP; Moon J; Samlowski W; Clark JI; Dakhil SR; Williamson S; Urba SG; Ensley J; Hussain MH;
Cancer; 2006 Jul; 107(2):319-27. PubMed ID: 16779801
[TBL] [Abstract][Full Text] [Related]
17. Ifosfamide in advanced epidermoid head and neck cancer.
Martín M; Diaz-Rubio E; González Larriba JL; Casado A; Sastre J; López-Vega JM; Almenarez J; Dominguez S
Cancer Chemother Pharmacol; 1993; 31(4):340-2. PubMed ID: 8422700
[TBL] [Abstract][Full Text] [Related]
18. Docetaxel, ifosfamide and cisplatin (DIP) in squamous cell carcinoma of the head and neck.
Specenier PM; Van Den Brande J; Schrijvers D; Huizing MT; Altintas S; Dyck J; Van Den Weyngaert D; Van Laer C; Vermorken JB
Anticancer Res; 2009 Dec; 29(12):5137-42. PubMed ID: 20044628
[TBL] [Abstract][Full Text] [Related]
19. Phase I study of paclitaxel, cisplatin, and ifosfamide in patients with recurrent or metastatic squamous cell cancer of the head and neck.
Benner SE; Lippman SM; Huber MH; Hong WK
Semin Oncol; 1995 Oct; 22(5 Suppl 12):22-5. PubMed ID: 7481857
[TBL] [Abstract][Full Text] [Related]
20. Phase II trial of ifosfamide in recurrent and metastatic head and neck cancer.
Buesa JM; Fernández R; Esteban E; Estrada E; Barón FJ; Palacio I; Gracia M; Lacave AJ
Ann Oncol; 1991 Feb; 2(2):151-2. PubMed ID: 1905150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]